Scynexis (SCYX) Return on Sales Growth (5y) (2018 - 2026)
Scynexis (SCYX) Return on Sales Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Scynexis | 61.87 Mn | -52.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.00 |
| Mar 31, 2026 | -1.00 |
| Mar 31, 2025 | 626.00 |
| Dec 31, 2024 | 343.00 |
| Sep 30, 2024 | 198.00 |
| Jun 30, 2024 | 128.00 |
| Mar 31, 2024 | 191.00 |
| Dec 31, 2023 | 136.00 |
| Sep 30, 2023 | 170.00 |
| Jun 30, 2023 | 102.00 |
| Mar 31, 2023 | 65.00 |
| Dec 31, 2022 | 103.00 |
| Sep 30, 2022 | 61.00 |
| Jun 30, 2022 | 114.00 |
| Mar 31, 2022 | 91.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 15.00 |
| Mar 31, 2020 | -640.00 |
| Dec 31, 2019 | -348.00 |
| Sep 30, 2019 | -209.00 |